'The drug is projected to be a blockbuster seller, with estimates putting it in the top 10 drugs by 2018 when it is expected to reach $5.3 billion in sales. A one-year course of Gilenya costs $48,000.
The drug was discovered by studying compounds used in Traditional Chinese Medicine, a 5,000-year-old medical art form that still out-performs western medicine at every level (cost, safety and effectiveness). Japanese researcher Tetsuro Fujita began studying what he calls "Himalayan fungus" in the 1980's, and his "discovery" (if you can even call it that, as Chinese Medicine has known about this for millennia) looks likely to earn Mitsubishi Tanabe Pharma Corp up to $5 billion.'
Read more...